Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor alpha stimulation is counteracted by nuclear

Valérie Benoit1, Alain Chariot, Laurence Delacroix

  • 1Laboratory of Medical Chemistry and Human Genetics, Center for Molecular and Cellular Therapy and Center for Research in Experimental Cancerology, University of Liege, Liege, Belgium.

Cancer Research
|April 17, 2004
PubMed

Insights

The oncoprotein HER-2/neu, a factor promoting cell survival, is cleaved by caspase-8 upon tumor necrosis factor alpha (TNF-alpha) stimulation. Nuclear factor kappaB (NFkappaB) activation inhibits this cleavage, revealing a new anti-apoptotic role for NFkappaB in breast cancer cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • HER-2/neu oncoprotein overexpression is linked to poor prognosis in breast cancer.
  • HER-2/neu acts as a prosurvival factor, influencing cancer cell survival and proliferation.
  • Tumor necrosis factor alpha (TNF-alpha) is a key cytokine involved in inflammation and apoptosis.

Purpose of the Study:

  • To investigate the role of HER-2/neu in TNF-alpha-induced apoptosis.
  • To identify new substrates and regulatory mechanisms of caspase-8 in breast cancer cells.
  • To elucidate the interplay between HER-2/neu cleavage, NFkappaB signaling, and apoptosis.

Main Methods:

  • Utilized MCF7 A/Z breast adenocarcinoma cells with defective NFkappaB activation.
  • Stimulated cells with TNF-alpha to induce caspase-8 activity and HER-2 cleavage.
  • Assessed HER-2 cleavage using Western blotting and analyzed the role of NFkappaB and c-FLIP.

Main Results:

  • Demonstrated that HER-2/neu is a novel substrate for caspase-8.
  • Showed that TNF-alpha stimulation triggers caspase-8-dependent HER-2 cleavage in NFkappaB-defective cells.
  • Confirmed that NFkappaB activation counteracts HER-2 cleavage by inducing the caspase-8 inhibitor c-FLIP.
  • Established that HER-2 cleavage contributes to TNF-alpha-induced apoptosis, as preventing cleavage protects cells.

Conclusions:

  • Proposed a novel model where NFkappaB exerts an antiapoptotic function by inhibiting TNF-alpha-triggered HER-2 cleavage.
  • Highlighted a new mechanism by which NFkappaB signaling modulates cell survival pathways in breast cancer.
  • Identified HER-2 cleavage as a critical step in TNF-alpha-mediated apoptosis, offering potential therapeutic targets.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...